Kura Oncology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $67.5 | $53.9 | $0.0 | — | — |
| Operating income | -$303.6 | -$193.2 | -$165.8 | -$139.9 | — |
| Net income | -$278.7 | -$174.0 | -$152.6 | -$135.8 | -$130.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$70.7 | $133.8 | -$125.0 | -$110.7 | -$105.7 |
Shares outstanding 88.8M · Free float 97.6%
Annual filing data through FY ended December 31, 2025; float as of August 29, 2026.